The effect of systemically administered bisphosphonates on bony healing after tooth extraction and osseointegration of dental implants in the rabbit maxilla

International Journal of Oral and Maxillofacial Implants

Volumn 28, Issue 5, 2013, Pages 1194-1200

  Kim, InSoo ^a   Ki, HyungChun ^a   Lee, Won ^a   Kim, Heesung ^a,b   Park, Jun Beom ^a  

^a The Catholic University of Korea   (South Korea)

^b Korea University   (South Korea)

Author keywords

Bisphosphonate related osteonecrosis of the jaws (bronj); Bisphosphonates; Dental implant; Initial stability; Tooth extraction; Wound healing

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BONE DENSITY CONSERVATION AGENT; DEXAMETHASONE; GLUCOCORTICOID; IMIDAZOLE DERIVATIVE; ZOLEDRONIC ACID; TOOTH IMPLANT;

ANIMAL; ARTICLE; BONE REGENERATION; BONE REMODELING; DRUG EFFECT; FEMALE; MAXILLA; PREMOLAR TOOTH; RABBIT; TOOTH EXTRACTION; TOOTH IMPLANT; WOUND HEALING; DRUG EFFECTS; SURGERY;

ANIMALS; BICUSPID; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; DENTAL IMPLANTS; DEXAMETHASONE; DIPHOSPHONATES; FEMALE; GLUCOCORTICOIDS; IMIDAZOLES; MAXILLA; OSSEOINTEGRATION; RABBITS; TOOTH EXTRACTION; WOUND HEALING;

EID: 84899468712     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: 10.11607/jomi.2685     Document Type: Article

References (41)

1. Allen MR, Burr DB. The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: So many hypotheses, so few data. J Oral Maxillofac Surg 2009;67: 61-70.
2. Madrid C, Sanz M. What impact do systemically administrated bisphosphonates have on oral implant therapy? A systematic review. Clin Oral Implants Res 2009;20(suppl 4): 87-95.
3. Russell RG. Bisphosphonates: The first 40 years. Bone 2011;49: 2-19.
4. Russell RG. Bisphosphonates: Mode of action and pharmacology. Pediatrics 2007;119(suppl 2): s150-s162.
5. Russell RG, Xia Z, Dunford JE, et al. Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy. Ann N Y Acad Sci 2007;1117: 209-257.
6. Khosla S. Increasing options for the treatment of osteoporosis. N Engl J Med 2009;361: 818-820.
7. Brunsvold MA, Chaves ES, Kornman KS, Aufdemorte TB, Wood R. Effects of a bisphosphonate on experimental periodontitis in monkeys. J Periodontol 1992;63: 825-830.
8. O’Uchi N, Nishikawa H, Yoshino T, et al. Inhibitory effects of YM175, a bisphosphonate, on the progression of experimental periodontitis in beagle dogs. J Periodontal Res 1998;33: 196-204.
9. Diel IJ, Bergner R, Grotz KA. Adverse effects of bisphosphonates: Current issues. J Support Oncol 2007;5: 475-482.
10. Walter C, Grotz KA, Kunkel M, Al-Nawas B. Prevalence of bisphosphonate associated osteonecrosis of the jaw within the field of osteonecrosis. Support Care Cancer 2007;15: 197-202.
11. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic. J Oral Maxillofac Surg 2003;61: 1115-1117.
12. Agarwal P, Rao NN. Bisphosphonate-associated osteonecrosis of the jaws. Indian J Dent Res 2012;23: 107-111.
13. Hasegawa Y, Kawabe M, Kimura H, Kurita K, Fukuta J, Urade M. Influence of dentures in the initial occurrence site on the prognosis of bisphosphonate-related osteonecrosis of the jaws: A retrospective study. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;114: 318-324.
14. Petcu EB, Ivanovski S, Wright RG, Slevin M, Miroiu RI, Brinzaniuc K. Bisphosphonate-related osteonecrosis of jaw (BRONJ): An antiangiogenic side-effect? Diagn Pathol 2012;7: 78.
15. Li YF, Hu J. Parathyroid hormone may be a promising therapy for bisphosphonate-related osteonecrosis of jaw bones. Int J Oral Maxillofac Surg 2013;42: 149-150.
16. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg 2009;67: 2-12.
17. Yamazaki T, Yamori M, Ishizaki T, et al. Increased incidence of osteonecrosis of the jaw after tooth extraction in patients treated with bisphosphonates: A cohort study. Int J Oral Maxillofac Surg 2012;41: 1397-1403
18. Akintoye SO, Hersh EV. Risks for jaw osteonecrosis drastically increases after 2 years of bisphosphonate therapy. J Evid Based Dent Pract 2012;12: 116-118.
19. Conte-Neto N, de Souza Bastos A, Spolidorio LC, Chierici Marcantonio RA, Marcantonio E, Jr. Long-term treatment with alendronate increases the surgical difficulty during simple exodontias-An in vivo observation in Holtzman rats. Head Face Med 2012;8: 20.
20. Otto S, Hafner S, Mast G, et al. Bisphosphonate-related osteonecrosis of the jaw: Is pH the missing part in the pathogenesis puzzle? J Oral Maxillofac Surg 2010;68: 1158-1161.
21. Kyrgidis A. Novel hypotheses in the etiopathogenesis of bisphosphonate- related osteonecrosis of the jaws. J Oral Maxillofac Surg 2009;67: 2554.
22. Curi MM, Cossolin GS, Koga DH, et al. Bisphosphonate-related osteonecrosis of the jaws-An initial case series report of treatment combining partial bone resection and autologous platelet-rich plasma. J Oral Maxillofac Surg 2011;69: 2465-2472.
23. Kushner GM, Alpert B. Bisphosphonate-related osteonecrosis of the jaws. Curr Opin Otolaryngol Head Neck Surg 2011;19: 302-306.
24. Roughead EE, McGeechan K, Sayer GP. Bisphosphonate use and subsequent prescription of acid suppressants. Br J Clin Pharmacol 2004;57: 813-816.
25. Salari P, Abdollahi M. Long term bisphosphonate use in osteoporotic patients; a step forward, two steps back. J Pharm Pharm Sci 2012;15: 305-317.
26. Sonis ST, Watkins BA, Lyng GD, Lerman MA, Anderson KC. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients. Oral Oncol 2009;45: 164-172.
27. Kikuiri T, Kim I, Yamaza T, et al. Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw-like disease in mice. J Bone Miner Res 2010;25: 1668-1679.
28. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues. The Sage-Schliff (sawing and grinding) technique. J Oral Pathol 1982;11: 318-326.
29. Allen MR, Burr DB. Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment. J Oral Maxillofac Surg 2008;66: 987-994.
30. Hikita H, Miyazawa K, Tabuchi M, Kimura M, Goto S. Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in rats. J Bone Miner Metab 2009;27: 663-672.
31. Senel FC, Kadioglu Duman M, Muci E, et al. Jaw bone changes in rats after treatment with zoledronate and pamidronate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010;109: 385-391.
32. Starck WJ, Epker BN. Failure of osseointegrated dental implants after diphosphonate therapy for osteoporosis: A case report. Int J Oral Maxillofac Implants 1995;10: 74-78.
33. Wang HL, Weber D, McCauley LK. Effect of long-term oral bisphosphonates on implant wound healing: Literature review and a case report. J Periodontol 2007;78: 584-594.
34. Bedogni A, Bettini G, Totola A, Saia G, Nocini PF. Oral bisphosphonate- associated osteonecrosis of the jaw after implant surgery: A case report and literature review. J Oral Maxillofac Surg 2010;68: 1662-1666.
35. Vescovi P, Nammour S. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review. Minerva Stomatol 2010;59: 181-203, 204-113.
36. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaw-2009 update. Aust Endod J 2009;35: 119-130.
37. Colella G, Campisi G, Fusco V. American Association of Oral and Maxillofacial Surgeons position paper: Bisphosphonate-Related Osteonecrosis of the Jaws-2009 update: The need to refine the BRONJ definition. J Oral Maxillofac Surg 2009;67: 2698-2699.
38. Grant BT, Amenedo C, Freeman K, Kraut RA. Outcomes of placing dental implants in patients taking oral bisphosphonates: A review of 115 cases. J Oral Maxillofac Surg 2008;66: 223-230.
39. Goss A, Bartold M, Sambrook P, Hawker P. The nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in dental implant patients: A South Australian case series. J Oral Maxillofac Surg 2010;68: 337-343.
40. Yoneda T, Hagino H, Sugimoto T, et al. Bisphosphonate-related osteonecrosis of the jaw: Position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons. J Bone Miner Metab 2010;28: 365-383.
41. Biasotto M, Chiandussi S, Zacchigna S, et al. A novel animal model to study non-spontaneous bisphosphonates osteonecrosis of jaw. J Oral Pathol Med 2010;39: 390-396.